{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Abioye AI"],"funding":["Eunice Kennedy Shriver National Institute of Child Health and Human Development","NICHD NIH HHS","NIDDK NIH HHS"],"pagination":["987-1001"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9987582"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["62(2)"],"pubmed_abstract":["<h4>Purpose</h4>Whether anemia type modifies the risk of pregnancy and newborn outcomes and the effectiveness of iron supplementation is unclear. We examined the association of iron deficiency anemia (IDA) and non-iron deficiency anemia (NIDA) on the risks of these outcomes and the extent to which anemia type modifies the impact of prenatal iron supplementation.<h4>Methods</h4>This was a secondary analysis of a placebo-controlled trial of iron supplementation among 1450 HIV-negative women in Tanzania. Eligibility criteria included gestational age < 27 weeks, hemoglobin > 85 g/L, and ferritin > 12 µg/L. Individuals were categorized as non-anemia, IDA or NIDA using hemoglobin, ferritin and CRP. Analyses were conducted using regression models and likelihood ratio tests.<h4>Results</h4>Compare"],"journal":["European journal of nutrition"],"pubmed_title":["The effect of iron supplementation on maternal iron deficiency anemia does not differ by baseline anemia type among Tanzanian pregnant women without severe iron deficiency anemia."],"pmcid":["PMC9987582"],"funding_grant_id":["U01 HD061232","K24 DK104676","P30 DK040561"],"pubmed_authors":["Aboud S","Fawzi WW","Abioye AI","Sudfeld CR","Hamer DH","Duggan CP","Premji Z","Hughes MD","Roberts DJ"],"additional_accession":[]},"is_claimable":false,"name":"The effect of iron supplementation on maternal iron deficiency anemia does not differ by baseline anemia type among Tanzanian pregnant women without severe iron deficiency anemia.","description":"<h4>Purpose</h4>Whether anemia type modifies the risk of pregnancy and newborn outcomes and the effectiveness of iron supplementation is unclear. We examined the association of iron deficiency anemia (IDA) and non-iron deficiency anemia (NIDA) on the risks of these outcomes and the extent to which anemia type modifies the impact of prenatal iron supplementation.<h4>Methods</h4>This was a secondary analysis of a placebo-controlled trial of iron supplementation among 1450 HIV-negative women in Tanzania. Eligibility criteria included gestational age < 27 weeks, hemoglobin > 85 g/L, and ferritin > 12 µg/L. Individuals were categorized as non-anemia, IDA or NIDA using hemoglobin, ferritin and CRP. Analyses were conducted using regression models and likelihood ratio tests.<h4>Results</h4>Compare","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Mar","modification":"2026-06-02T19:25:51.016Z","creation":"2025-04-04T20:40:55.297Z"},"accession":"S-EPMC9987582","cross_references":{"pubmed":["36344770"],"doi":["10.1007/s00394-022-03029-0"]}}